Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Alzheimer's in Long-Term Care--Treatment for Agitation [NA]
This clinical trial update reports results for a treatment of agitation in Alzheimer's disease patients in long-term care; the study has com…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease [Phase 4]
Phase 4 clinical trial assessing the impact of choline acetyltransferase and apolipoprotein Epsilon gene polymorphisms on response to donepe…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals [Phase 2]
This Phase 2 trial evaluated whether the [18F]-AV-45 PET scan (Florbetapir F-18) can distinguish Alzheimer's disease from cognitively normal…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
This clinical trial update reports the performance of AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, in US patients n…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease [Phase 3]
Phase 3 clinical trial evaluating galantamine for Alzheimer's disease has completed, with results posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-06-27Clinical Trial Update: Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease [Phase 1, Phase 2]
This entry reports a Phase 1/2 trial investigating chronic electrical stimulation of the hypothalamus/fornix as a treatment for Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) [Phase 3]
Phase 3 clinical trial update evaluating inter-reader reliability using imaging in Alzheimer's disease and mild cognitive impairment.
-
CLINICAL_TRIALS research · 2012-06-22Clinical Trial Update: Evaluation of a Diet in Patients With Senile Dementia [NA]
Clinical trial update on evaluating a dietary intervention in patients with senile dementia, including Alzheimer's disease and Parkinson's d…
-
CLINICAL_TRIALS research · 2012-06-20Clinical Trial Update: Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study [NA]
This document provides an update on a three-year pilot to establish the Taiwan Alzheimer's Disease Neuroimaging Initiative. It outlines the …
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease [Phase 3]
Open-label extension study update for 23 mg donepezil sustained-release in moderate to severe Alzheimer's disease; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease [NA]
This clinical trial update describes a terminated study evaluating pitavastatin for mild to moderate Alzheimer's disease, with hypercholeste…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Effects of ONO-2506PO in Patients With Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating ONO-2506PO in patients with Alzheimer's disease has completed.
-
FDA approval · 2012-06-12FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for rivastigmine tartrate as a generic drug. This approval enables a gen…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease [Phase 2]
Phase 2 trial results report preliminary efficacy and safety for ST101 in combination with Aricept (donepezil) in Alzheimer's disease. The s…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease [Phase 2]
Phase 2 trial investigating ST101 for Alzheimer's disease has been completed, reporting preliminary efficacy and safety findings.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans [NA]
A completed clinical trial evaluated a web-based training program for educating physicians on interpreting Florbetapir-PET scans, with resul…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Evaluation of PET Scan Timing Relative to AV-45 Injection Time [NA]
Clinical trial update evaluating the timing of PET imaging relative to AV-45 (florbetapir F-18) injection in Alzheimer's disease; results we…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Evaluation of Physician Training Methods to Read Florbetapir-PET Scans [NA]
A completed clinical trial sponsored by Avid Radiopharmaceuticals evaluated methods for training physicians to read Florbetapir-PET scans in…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
The Phase 2 randomized trial of FK962 in mild-to-moderate Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Enhancing Quality of Life for Nursing Home Residents [Phase 2]
A Phase 2 clinical trial sponsored by Penn State University evaluating an intervention to improve quality of life for nursing home residents…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
This document reports a Phase 2 safety study of passive immunization in patients with mild to moderate Alzheimer's disease. The current stat…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Multicenter Vitamin E Trial in Aging Persons With Down Syndrome [Phase 3]
The document reports completion of the multicenter Phase 3 trial of vitamin E in aging individuals with Down syndrome and Alzheimer’s diseas…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 [Phase 3]
Autopsy follow-up data from subjects previously imaged with Florbetapir F-18 PET in the Phase 3 trial 18F-AV-45-A07 for Alzheimer's disease …
-
CLINICAL_TRIALS research · 2012-05-07Clinical Trial Update: Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain [Phase 3]
A Phase 3 clinical trial assessed the correlation between Florbetapir F-18 PET imaging and amyloid pathology in the brain for Alzheimer's di…
-
CLINICAL_TRIALS research · 2012-05-04Clinical Trial Update: Vitamin E in Aging Persons With Down Syndrome [Phase 3]
A Phase 3 clinical trial evaluating vitamin E in aging individuals with Down syndrome and Alzheimer's disease; the current status is unknown…